Skip to main content

Mark Messier

Articles From This Author

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS
BIODMNKD

The Run-Up Trade: Biodel's Insulin Trial Results

By Mark Messier
May 30, 2013 8:00 AM EDT
Why Raptor Is Down, Despite Possibility of New Drug Approval
STOCKS
KERXRMTI

Rockwell Medical Run-Up Trade Follows Financing

By Mark Messier
May 21, 2013 8:00 AM EDT
FDA Tells Delcath No Approval Without New Clinical Trial
STOCKS
HSPSNTA

Synta Is Run-Up to ASCO Lung Cancer Data

By Mark Messier
May 14, 2013 10:16 AM EDT
Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS
ZIOP

Expecting Ziopharm Shares To Run Into Phase III Data At Month's End

By Mark Messier
Mar 4, 2013 7:00 AM EST
Why Raptor Is Down, Despite Possibility of New Drug Approval
STOCKS
DVAX

Run-Up Trade Into Dynavax's FDA Approval Decision

By Mark Messier
Feb 13, 2013 7:00 AM EST
First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS
TTNP

Titan Pharma: Run-Up Trade Into March FDA Panel

By Mark Messier
Jan 31, 2013 6:03 AM EST
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS
APPA

A.P. Pharma Run-Up Trade Into FDA Approval Decision

By Mark Messier
Jan 22, 2013 8:32 AM EST
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS
ALXADSCOEXEL

Shorting Alexza Pharma On FDA's Adasuve Approval

By Mark Messier
Dec 19, 2012 7:00 AM EST
First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS
ANAC

Anacor Pharma: Run-Up Trade Into January Trial Data

By Mark Messier
Dec 11, 2012 8:29 AM EST
One Short Seller's Take On Arena's Slow Belviq Launch
STOCKS
HPTXSUPN

Hyperion Shares Poised to Run Up Ahead of FDA Decision

By Mark Messier
Dec 5, 2012 8:00 AM EST
FDA Tells Delcath No Approval Without New Clinical Trial
STOCKS
ALXA

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

By Mark Messier
Nov 20, 2012 8:03 AM EST
Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS
CLSNCPRX

Celsion: Run-Up Trade Into Thermodox Results

By Mark Messier
Nov 14, 2012 7:01 AM EST
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS
SUPN

Short Trade: Supernus IPO Lock-Up

By Mark Messier
Oct 31, 2012 7:00 AM EDT
Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS
ACADCYCCHEB

How to Prep for the Inevitable Bursting of the Biotech Stock Bubble

By Mark Messier
Oct 17, 2012 7:00 AM EDT
Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS
APPADCTH

AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades

By Mark Messier
Oct 9, 2012 7:05 AM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS
HEB

How to Trade Hemispherx Even If You Hate the Stock

By Mark Messier
Oct 2, 2012 10:48 AM EDT
Spectrum Pharma Implodes On Colossal Fusilev Sales Warning
STOCKS
ZGNX

Zogenix: Three Shots At Run-Up Trade

By Mark Messier
Sep 26, 2012 8:00 AM EDT
Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS
ACADCPRXSRPT

Acadia Pharma, Sarepta Therapeutics: How to Trade Into Trial Results

By Mark Messier
Sep 19, 2012 7:31 AM EDT
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS
DVAX

Dynavax: The BioRunUp Trade Into An FDA Panel

By Mark Messier
Sep 11, 2012 11:34 AM EDT